KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Interest Expenses (2016 - 2018)

Zimmer Biomet Holdings has reported Interest Expenses over the past 8 years, most recently at $68.3 million for Q3 2018.

  • Quarterly results put Interest Expenses at $68.3 million for Q3 2018, down 17.01% from a year ago — trailing twelve months through Jun 2019 was $68.3 million (down 78.46% YoY), and the annual figure for FY2017 was $327.5 million, down 8.49%.
  • Interest Expenses for Q3 2018 was $68.3 million at Zimmer Biomet Holdings, down from $75.9 million in the prior quarter.
  • Over the last five years, Interest Expenses for ZBH hit a ceiling of $91.5 million in Q3 2016 and a floor of $11.6 million in Q2 2014.
  • Median Interest Expenses over the past 5 years was $80.0 million (2017), compared with a mean of $63.0 million.
  • Biggest five-year swings in Interest Expenses: crashed 36.61% in 2014 and later soared 462.5% in 2015.
  • Zimmer Biomet Holdings' Interest Expenses stood at $16.0 million in 2014, then soared by 462.5% to $90.0 million in 2015, then grew by 0.11% to $90.1 million in 2016, then decreased by 11.21% to $80.0 million in 2017, then decreased by 14.62% to $68.3 million in 2018.
  • The last three reported values for Interest Expenses were $68.3 million (Q3 2018), $75.9 million (Q2 2018), and $78.9 million (Q1 2018) per Business Quant data.